Please assess the completion status of the following clinical trial:

Trial Title: Betaquik as an Adjunct to Dietary Management of Epilepsy in Adults on the Modified Atkins Diet

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of epilepsy; suffering from recurrent seizures (\> or equal to 2 seizures per month) despite at least two anticonvulsant medication trials.~* Aged 18 years and above.~* Not on the ketogenic diet.~* Absence of any metabolic or mitochondrial disorder that precludes the use of MCT and the ketogenic diet.~* Willingly given, written, informed consent from the patient or caregiver.~* Ability to comply with study protocol and keep written records.~Exclusion Criteria:~* Non-compliant with previously recommended treatments.~* Significantly underweight (BMI \<18.5), untreated dysphagia, or severe gastroesophageal reflux.~* Kidney disease, including history of nephrolithiasis.~* Uncontrolled or untreated hypercholesterolemia (\>300mg/dL) or hypertriglyceridemia (\>200mg/dL) within the last two years.~* Prior use of Betaquik at any time for any duration.~* Any serious medical, psychological, or social condition precluding the study intervention.~* Use of additional macro/micronutrient supplement during the study period, unless clinical indicated and prescribed by the investigator (must be recorded electronic medical records).~* Women who are pregnant/breastfeeding at the start of the study or planning to become pregnant during the study period.~* N.B.: Women who become pregnant unexpectedly during this study may, in consultation with their doctor, continue on the study's dietary product if they wish but will not have any investigations that would not normally be carried out during pregnancy.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Betaquik (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).